| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |